PuSH - Publication Server of Helmholtz Zentrum München

Oncogenic potential of hepatitis B virus encoded proteins.

Curr. Opin. Virol. 14, 109-115 (2015)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
Due to the limited treatment options hepatocellular carcinoma (HCC) is one of the leading causes of cancer related death, and hepatitis B virus (HBV) infection is the major risk factor for development of HCC worldwide. HCC is typically preceded by chronic inflammation, but may also develop in the absence of liver disease on the basis of HBV infection and even when virus replication is controlled by antivirals. In this situation, HBV antigen expression persists and direct oncogenic effects of HBV are integration of the viral DNA into the host genome as well as direct effects of viral proteins. These factors have to be taken into account in order to personalize HCC surveillance in CHB and unravel novel therapeutic approaches.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
6.064
1.396
18
21
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Review
Language english
Publication Year 2015
HGF-reported in Year 2015
ISSN (print) / ISBN 1879-6257
e-ISSN 1879-6265
Quellenangaben Volume: 14, Issue: , Pages: 109-115 Article Number: , Supplement: ,
Publisher Elsevier
Reviewing status Peer reviewed
POF-Topic(s) 30203 - Molecular Targets and Therapies
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Research field(s) Immune Response and Infection
PSP Element(s) G-502700-003
G-551600-001
PubMed ID 26426688
Erfassungsdatum 2015-11-11